Atom Investors’s Genomic Health, Inc. GHDX Stock Holding History

Atom Investors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,453	Closed	-$382K	–	681
2019 Q1	$382K	Buy	+5,453	New	+$404K	0.03%	387

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Atom Investors's GHDX Position: Q2 2019 in Review

Atom Investors sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 5,453 shares — an estimated $382K sold.

Atom Investors first reported a position in GHDX in Q1 2019 and held it in 1 quarter. The position peaked at $382K in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Atom Investors reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Atom Investors sold 5,453 Genomic Health, Inc. shares in Q2 2019, an estimated $382K.
Atom Investors first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 1 quarter.
Atom Investors's Genomic Health, Inc. position peaked at $382K in Q1 2019.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Atom Investors's 13F filing for Q2 2019, filed 14 Aug 2019.